Do we need more than one antidepressant for patients with major depressive disorder?

References

• Practice guideline for the treatment of patients with major depressive disorder (revision). American Psychiatric Association. Am. J. Psychiatry157(4 Suppl.), 1–45 (2000).
   Google Scholar
• Bauer M, Whybrow PC, Angst J, Versiani M, Moller HJ. World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for biological treatment of unipolar depressive disorders, part 1: acute and continuation treatment of major depressive disorder. World J. Biol. Psychiatry3(1), 5–43 (2002).
   PubMedGoogle Scholar
• Anderson IM, Ferrier IN, Baldwin RC et al. Evidence-based guidelines for treating depressive disorders with antidepressants: a revision of the 2000 British Association for Psychopharmacology guidelines. J. Psychopharmacol.22(4), 343–396 (2008).
   PubMed Web of Science ®Google Scholar
• Kennedy SH, Lam RW, Cohen NL, Ravindran AV. Clinical guidelines for the treatment of depressive disorders. IV. Medications and other biological treatments. Can. J. Psychiatry46(Suppl. 1), S38–S58 (2001).
   PubMedGoogle Scholar
• Rush AJ, Trivedi MH, Stewart JW et al. Combining medications to enhance depression outcomes (CO-MED): acute and long-term outcomes of a single-blind randomized study. Am. J. Psychiatry168(7), 689–701 (2011).
   PubMed Web of Science ®Google Scholar
• Fleurence R, Williamson R, Jing Y et al. A systematic review of augmentation strategies for patients with major depressive disorder. Psychopharmacol. Bull.42(3), 57–90 (2009).
   PubMed Web of Science ®Google Scholar
• Thase ME, Kornstein SG, Germain JM, Jiang Q, Guico-Pabia C, Ninan PT. An integrated analysis of the efficacy of desvenlafaxine compared with placebo in patients with major depressive disorder. CNS Spectr.14(3), 144–154 (2009).
   PubMed Web of Science ®Google Scholar
• Wisniewski SR, Rush AJ, Nierenberg AA et al. Can Phase III trial results of antidepressant medications be generalized to clinical practice? A STAR*D report. Am. J. Psychiatry166(5), 599–607 (2009).
   PubMed Web of Science ®Google Scholar
• Thase ME, Pritchett YL, Ossanna MJ, Swindle RW, Xu J, Detke MJ. Efficacy of duloxetine and selective serotonin reuptake inhibitors: comparisons as assessed by remission rates in patients with major depressive disorder. J. Clin. Psychopharmacol.27(6), 672–676 (2007).
   PubMed Web of Science ®Google Scholar
• Papakostas GI, Fava M. Does the probability of receiving placebo influence clinical trial outcome? A meta-regression of double-blind, randomized clinical trials in MDD. Eur. Neuropsychopharmacol.19(1), 34–40 (2009).
   PubMed Web of Science ®Google Scholar
• Gaynes BN, Warden D, Trivedi MH, Wisniewski SR, Fava M, Rush AJ. What did STAR*D teach us? Results from a large-scale, practical, clinical trial for patients with depression. Psychiatr. Serv.60(11), 1439–1445 (2009).
   PubMed Web of Science ®Google Scholar
• Rush AJ. Star D. Lessons learned and future implications. Depress. Anxiety28(7), 521–524 (2011).
   PubMedGoogle Scholar
• Thase ME. Antidepressant combinations: widely used, but far from empirically validated. Can. J. Psychiatry56(6), 317–323 (2011).
   PubMedGoogle Scholar
• Blier P, Gobbi G, Turcotte JE et al. Mirtazapine and paroxetine in major depression: a comparison of monotherapy versus their combination from treatment initiation. Eur. Neuropsychopharmacol.19(7), 457–465 (2009).
   PubMed Web of Science ®Google Scholar
• Blier P, Ward HE, Tremblay P, Laberge L, Hebert C, Bergeron R. Combination of antidepressant medications from treatment initiation for major depressive disorder: a double-blind randomized study. Am. J. Psychiatry167(3), 281–288 (2010).
   PubMed Web of Science ®Google Scholar
• Papakostas GI, Worthington JJ 3rd, Iosifescu DV et al. The combination of duloxetine and bupropion for treatment-resistant major depressive disorder. Depress. Anxiety23(3), 178–181 (2006).
   PubMed Web of Science ®Google Scholar
• Leuchter AF, Lesser IM, Trivedi MH et al. An open pilot study of the combination of escitalopram and bupropion-SR for outpatients with major depressive disorder. J. Psychiatr. Pract.14(5), 271–280 (2008).
   PubMed Web of Science ®Google Scholar
• Stewart JW, McGrath PJ, Deliyannides RA, Quitkin FM. Does dual antidepressant therapy as initial treatment hasten and increase remission from depression? J. Psychiatr. Pract.15(5), 337–345 (2009).
   PubMed Web of Science ®Google Scholar
• Carpenter LL, Yasmin S, Price LH. A double-blind, placebo-controlled study of antidepressant augmentation with mirtazapine. Biol. Psychiatry51(2), 183–188 (2002).
   PubMed Web of Science ®Google Scholar
• Nelson JC, Mazure CM, Jatlow PI, Bowers MB Jr, Price LH. Combining norepinephrine and serotonin reuptake inhibition mechanisms for treatment of depression: a double-blind, randomized study. Biol. Psychiatry55(3), 296–300 (2004).
   PubMed Web of Science ®Google Scholar
• Hirschfeld RM. Efficacy of SSRIs and newer antidepressants in severe depression: comparison with TCAs. J. Clin. Psychiatry60(5), 326–335 (1999).
   PubMed Web of Science ®Google Scholar
• Joyce PR, Mulder RT, Luty SE, McKenzie JM, Rae AM. A differential response to nortriptyline and fluoxetine in melancholic depression: the importance of age and gender. Acta Psychiatr. Scand.108(1), 20–23 (2003).
   PubMed Web of Science ®Google Scholar
• Bobo WV, Chen H, Trivedi MH et al. Randomized comparison of selective serotonin reuptake inhibitor (escitalopram) monotherapy and antidepressant combination pharmacotherapy for major depressive disorder with melancholic features: a CO-MED report. J. Affect. Disord.133(3), 467–476 (2011).
   PubMedGoogle Scholar
• Wiersma JE, Hovens JG, van Oppen P et al. The importance of childhood trauma and childhood life events for chronicity of depression in adults. J. Clin. Psychiatry70(7), 983–989 (2009).
   PubMed Web of Science ®Google Scholar
• Blasey CM, Debattista C, Roe R, Block T, Belanoff JK. A multisite trial of mifepristone for the treatment of psychotic depression: a site-by-treatment interaction. Contemp. Clin. Trials30(4), 284–288 (2009).
   PubMed Web of Science ®Google Scholar
• Bridge JA, Birmaher B, Iyengar S, Barbe RP, Brent DA. Placebo response in randomized controlled trials of antidepressants for pediatric major depressive disorder. Am. J. Psychiatry166(1), 42–49 (2009).
   PubMed Web of Science ®Google Scholar